Indonesia · Delayed Price · Currency is IDR PT Merck Tbk Statistics
Total Valuation
PT Merck Tbk has a market cap or net worth of IDR 1.55 trillion. The enterprise value is 1.10 trillion.
| Market Cap | 1.55T |
| Enterprise Value | 1.10T |
Important Dates
The next estimated earnings date is Thursday, April 1, 2027.
| Earnings Date | Apr 1, 2027 |
| Ex-Dividend Date | Jun 8, 2026 |
Share Statistics
PT Merck Tbk has 448.00 million shares outstanding.
| Current Share Class | 448.00M |
| Shares Outstanding | 448.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.17% |
| Float | 59.81M |
Valuation Ratios
The trailing PE ratio is 6.48.
| PE Ratio | 6.48 |
| Forward PE | n/a |
| PS Ratio | 1.11 |
| PB Ratio | 1.61 |
| P/TBV Ratio | 1.62 |
| P/FCF Ratio | 3.60 |
| P/OCF Ratio | 3.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.42, with an EV/FCF ratio of 2.55.
| EV / Earnings | 4.54 |
| EV / Sales | 0.79 |
| EV / EBITDA | 2.42 |
| EV / EBIT | 3.30 |
| EV / FCF | 2.55 |
Financial Position
The company has a current ratio of 5.34, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.34 |
| Quick Ratio | 3.50 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.04 |
| Interest Coverage | 143.23 |
Financial Efficiency
Return on equity (ROE) is 26.76% and return on invested capital (ROIC) is 39.01%.
| Return on Equity (ROE) | 26.76% |
| Return on Assets (ROA) | 18.62% |
| Return on Invested Capital (ROIC) | 39.01% |
| Return on Capital Employed (ROCE) | 32.46% |
| Weighted Average Cost of Capital (WACC) | 5.36% |
| Revenue Per Employee | 4.16B |
| Profits Per Employee | 720.60M |
| Employee Count | 358 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 2.29 |
Taxes
In the past 12 months, PT Merck Tbk has paid 108.93 billion in taxes.
| Income Tax | 108.93B |
| Effective Tax Rate | 31.35% |
Stock Price Statistics
The stock price has increased by +11.29% in the last 52 weeks. The beta is 0.19, so PT Merck Tbk's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +11.29% |
| 50-Day Moving Average | 3,731.80 |
| 200-Day Moving Average | 3,638.35 |
| Relative Strength Index (RSI) | 39.07 |
| Average Volume (20 Days) | 17,455 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Merck Tbk had revenue of IDR 1.38 trillion and earned 238.52 billion in profits. Earnings per share was 532.40.
| Revenue | 1.38T |
| Gross Profit | 585.26B |
| Operating Income | 327.84B |
| Pretax Income | 347.45B |
| Net Income | 238.52B |
| EBITDA | 438.69B |
| EBIT | 327.84B |
| Earnings Per Share (EPS) | 532.40 |
Balance Sheet
The company has 465.12 billion in cash and 15.96 billion in debt, with a net cash position of 449.17 billion or 1,002.61 per share.
| Cash & Cash Equivalents | 465.12B |
| Total Debt | 15.96B |
| Net Cash | 449.17B |
| Net Cash Per Share | 1,002.61 |
| Equity (Book Value) | 949.23B |
| Book Value Per Share | 2,118.83 |
| Working Capital | 879.39B |
Cash Flow
In the last 12 months, operating cash flow was 447.80 billion and capital expenditures -22.39 billion, giving a free cash flow of 425.41 billion.
| Operating Cash Flow | 447.80B |
| Capital Expenditures | -22.39B |
| Depreciation & Amortization | 110.85B |
| Net Borrowing | -6.29B |
| Free Cash Flow | 425.41B |
| FCF Per Share | 949.59 |
Margins
Gross margin is 42.54%, with operating and profit margins of 23.83% and 17.34%.
| Gross Margin | 42.54% |
| Operating Margin | 23.83% |
| Pretax Margin | 25.26% |
| Profit Margin | 17.34% |
| EBITDA Margin | 31.89% |
| EBIT Margin | 23.83% |
| FCF Margin | 30.92% |
Dividends & Yields
This stock pays an annual dividend of 275.00, which amounts to a dividend yield of 7.97%.
| Dividend Per Share | 275.00 |
| Dividend Yield | 7.97% |
| Dividend Growth (YoY) | 61.76% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 51.44% |
| FCF Payout Ratio | 28.96% |
| Buyback Yield | n/a |
| Shareholder Yield | 8.04% |
| Earnings Yield | 15.43% |
| FCF Yield | 27.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on December 21, 2015. It was a forward split with a ratio of 20.
| Last Split Date | Dec 21, 2015 |
| Split Type | Forward |
| Split Ratio | 20 |
Scores
PT Merck Tbk has an Altman Z-Score of 7.5 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.5 |
| Piotroski F-Score | 6 |